Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Platinum Wahab Nusantara Tbk. (TGUK)

Organon Pharma Indonesia Tbk.Trading
Platinum Wahab Nusantara Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Organon Pharma Indonesia Tbk. dan Platinum Wahab Nusantara Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Platinum Wahab Nusantara Tbk. diperdagangkan di Rp91 (kapitalisasi pasar 296,43 M, volume 24 jam 11,14 jt). Perbedaan utamanya: Platinum Wahab Nusantara Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

SCPITGUK
Kapitalisasi Pasar
104,4 M296,43 M
Volume
11,14 jt
Lot
111,42 rb
Perputaran
972,2 jt
Harga Rata-rata
87,26
Nilai Transaksi
972,2 jt
Harga Ekuilibrium Indikatif
91
Volume Ekuilibrium Indikatif
47,08 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SCPI
Lihat detail
TGUK
Lihat detail

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI

Tentang Platinum Wahab Nusantara Tbk.

PT Platinum Wahab Nusantara Tbk. (the Company) was established based on Deed No. 16 dated June 6, 2018 of Notary Dr. Sugih Haryati, S.H., M.Kn., notary in Kota Tangerang. The Company started its commercial activities since 2018, by operating under the trademarks of "Teguk".

Selengkapnya di halaman TGUK